پیام خود را بنویسید

دکتر سید آیدین ساجدی : ِDr Seyed Aidin Sajedi

 | تاریخ ارسال: 1402/7/30 | 

Dr Seyed Aidin Sajedi

۱. Mohammadianinejad SE, Abbasi V, Sajedi SA, Majdinasab N, Abdollahi F, Hajmanouchehri R, et al. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial. Clinical neuropharmacology. ۲۰۱۱;۳۴(۴):۱۷۴-۷
۲. Shahripour RB, Mohammadianinejad SE, Sajedi SA, Tarahhomi S. Report of a Known Case of Rheumatoid Arthritis and Cerebral Vasculitis with a Proper Response to Corticosteroid and Cyclophosphamide Pulse Therapy. Journal of Isfahan Medical School. ۲۰۱۱;۲۹(۱۲۹); ۱۸۸-۱۹۵
۳. Shahripour RB, Shamsaei G, Pakdaman H, Majdinasab N, Nejad EM, Sajedi SA, et al. The effect of NeuroAiD™(MLC۶۰۱) on cerebral blood flow velocity in subjects&#۳۹; post brain infarct in the middle cerebral artery territory. European journal of internal medicine. ۲۰۱۱;۲۲(۵):۵۰۹-۱۳
۴. Sajedi SA, Abdollahi F. Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of ۱۱۱ locations in ۲۴ countries. BMC neurology. ۲۰۱۲;۱۲(۱):۱
۵. Azarpazhooh MR, Shahripour RB, Kapral MK, Mokhber N, Shoeibi A, Farzadfard MT, Rafati MR, Thrift AG, Morovatdar N, Sajedi SA, Azarpazhooh A. Incidence of first ever stroke during Hajj ceremony. BMC neurology. ۲۰۱۳;۱۳(۱):۱
۶. Abdollahi F, Sajedi SA. Correlation of multiple sclerosis (MS) incidence trends with solar and geomagnetic indices: Time to revise the method of reporting MS epidemiological data. Iranian journal of neurology. ۲۰۱۴;۱۳(۲):۶۴-۶۹
۷. Mohammadianinejad SE, Majdinasab N, Sajedi SA, Abdollahi F, Moqaddam MM, Sadr F. The effect of lithium in post-stroke motor recovery: a double-blind, placebo-controlled, randomized clinical trial. Clinical neuropharmacology. ۲۰۱۴;۳۷(۳):۷۳-۸
۸. Shahripour RB, Mortazavi MM, Barlinn K, Keikhaei B, Mousakhani H, Azarpazhooh MR, Oghbaee M, Sajedi SA, Kepplinger J, Tubbs RS, Albright KC, Alexandrov AV. Can STOP Trial Velocity Criteria Be Applied to Iranian Children with Sickle Cell Disease? Journal of stroke. ۲۰۱۴;۱۶(۲):۹۷-۱۰۱
۹. Sajedi SA, Abdollahi F. Geomagnetic disturbance: A new field in multiple sclerosis research. Clinical Neurology and Neurosurgery. ۲۰۱۶: ۱۵۱; ۱۴۲
۱۰.  Sajedi SA, Abdollahi F. Multiple Sclerosis and Geomagnetic Disturbances: Investigating a Potentially Important Environmental Risk Factor. In: Ibaraki M, Mori H, editors. Progress in Medical Geology.​ Cambridge Scholars Publishing; Newcastle. ۲۰۱۷ 
۱۱. Sajedi SA, Abdollahi F. Which Environmental Factor Is Correlated with Long-Term Multiple Sclerosis Incidence Trends: Ultraviolet B Radiation or Geomagnetic Disturbances? Multiple Sclerosis International. ۲۰۱۷: ۱-۱۱
۱۲. Iaffaldano P, Simone M, G Lucisano G,
(...), Sajedi SA, (...) , McCombefrom P, Grand&#۳۹;Maison F. Prognostic indicators in pediatric clinically isolated syndrome. Annals of Neurology. ۲۰۱۷; ۸۱ (۵): ۷۲۹-۷۳۹
۱۳. 
Abdollahi F, Sajedi SA, Majdinasab N, Saghatoleslami M, Rad HS, Ghorbani A, Kiarashi N. Is there an association between brain iron accumulations with blood iron metabolism markers in multiple sclerosis patients?. Multiple Sclerosis International. ۲۰۱۷; ۲۳ (۱): ۱۲-۱۲
۱۴. Sajedi SA. Time to consider alternative environmental risk factor rather than ultra violet-B for multiple sclerosis. Multiple Sclerosis and Related Disorders. ۲۰۱۸: ۲۴; ۴۷
۱۵. Signori A, Izquierdo G, Lugaresi A, (...), 
Sajedi SA, (...), Sormani, MP, Trojano M. Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis. Multiple Sclerosis Journal. ۲۰۱۸: ۲۴ (۵): ۶۴۲-۶۵۲
۱۶. Hughes J, Jokubaitis V, Lugaresi A, (...), 
Sajedi SA, (...), Quddus, S, Hinson E. Association of Inflammation and Disability Accrual in Patients with Progressive-Onset Multiple Sclerosis. JAMA Neurology. ۲۰۱۸; ۷۵ (۱۱):۱۴۰۷-۱۴۱۵
۱۷. Mohammadianinejad SE, Majidinasab N, Nejati A, Hatamian H, Mehramiri A, Sajedi SA, Hesam S. Tapering Oral Steroid Treatment After IV Methylprednisolone Pulse Therapy in Demyelinating Optic Neuritis. Caspian Journal of Neurological Sciences. ۲۰۱۸; ۴ (۱): ۱-۵

۱۸. Sajedi SAReader response: Incidence of MS has increased markedly over ۶ decades in Denmark particularly with late onset and in women. Neurology.۲۰۱۹; ۹۲ (۸): ۳۹۷
۱۹. 
Y Zhou, SB Claflin, J Stankovich, (...), SA Sajedi, (...), Bruce V Taylor. Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype. Multiple Sclerosis Journal. ۲۰۲۰
۲۰. 
Shahjouei S, Naderi S, Li J, (...), Sajedi SA, (...), Abedi V, Zand, R. Risk of stroke in hospitalized SARS-CoV-۲ infected patients: A multinational study. Ebiomedicine. ۲۰۲۰; ۵۹: ۱۰۲۹۳۹

۲۱. Shima Shahjouei, Georgios Tsivgoulis, Ghasem Farahmand, (...), Seyed Aidin Sajedi, (...), Jiang Li, Vida Abedi, Ramin Zand. SARS-CoV-۲ and Stroke Characteristics: A Report from the Multinational COVID-۱۹ Stroke Study GroupStroke. ۲۰۲۱; ۵۲.۵: e۱۱۷-e۱۳۰
۲۱. 
C Daruwalla, V Shaygannejad, S Ozakbas, EK Havrdova, D Horakova, ...و SA Sajedi, ..., et al. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. ۲۰۲۳: ۱۳۵۲۴۵۸۵۲۳۱۱۵۱۹۵۱
۲۲. Han Yong Wunrow*, Rose G Bender*, Avina Vongpradith, ..., 
Seyed Aidin Sajedi, ... et al. Global, regional, and national burden of meningitis and its aetiologies, ۱۹۹۰–۲۰۱۹: a systematic analysis for the Global Burden of Disease Study ۲۰۱۹. The Lancet Neurology. ۲۰۲۳: ۲۲ (۸); ۶۸۵-۷۱۱
۲۳. Ying Li, Alice Saul, Bruce Taylor, ..., 
Seyed Aidin Sajedi, ..., et al. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies. Journal of Neurology.۲۰۲۳: ۱-۱۴


دفعات مشاهده: 801 بار   |   دفعات چاپ: 228 بار   |   دفعات ارسال به دیگران: 0 بار   |   0 نظر



CAPTCHA


کلیه حقوق این وب سایت متعلق به مرکز تحقیقات علوم اعصاب می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2024 All Rights Reserved | olom aasab

Designed & Developed by : Yektaweb